What is the Invex Therapeutics (ASX: IXC) share price?
The IXC share price is $0.115, down 11.54% for the day, based on the latest available ASX market data.
What is Invex Therapeutics's market capitalisation?
Invex Therapeutics has a market capitalisation of $8.6M, making it the 1532nd-largest security listed on the ASX.
Does Invex Therapeutics pay a dividend?
IXC does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.
Is Invex Therapeutics profitable?
In its most recent reported period (ending 31 Dec 2025), IXC reported revenue of $0 and a net loss of $715,582.
How many IXC shares are on issue?
Invex Therapeutics has approximately 75,153,852 shares on issue, based on its market capitalisation of $8.6M and current share price.
What sector is Invex Therapeutics in?
Invex Therapeutics is classified in the Healthcare sector, within the Biotechnology industry on the ASX.
When did Invex Therapeutics list on the ASX?
Invex Therapeutics listed on the Australian Securities Exchange on 5 July 2019.
